HuGE Literature Finder
Records
1
-
4
The role of phase I and II genetic polymorphisms, smoking, alcohol and cancer family history, in the risk of developing testicular cancer. Pharmacogenetics and genomics 2019 May . Roco Angela, Lavanderos Alejandra, Cayún Juan P, Acevedo Cristian, Celedón Cesar, Rubilar Juan C, Sandoval Christopher, Cerpa Leslie, García-Martín Elena, Agúndez Jose A, Esguevillas Gara, Amo Gemma, Canepa Angelo, Cerda Berta, Peña Karina, Cáceres Dante D, Varela Nelson M, Quiñones Luis |
Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients. Frontiers in pharmacology 2019 10 206. Lavanderos María A, Cayún Juan P, Roco Ángela, Sandoval Christopher, Cerpa Leslie, Rubilar Juan C, Cerro Roberto, Molina-Mellico Sebastián, Celedón Cesar, Cerda Berta, García-Martín Elena, Agúndez José A G, Acevedo Cristián, Peña Karina, Cáceres Dante D, Varela Nelson M, Quiñones Luis |
Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Feb 25 (6): 708-14. Oldenburg Jan, Kraggerud Sigrid M, Cvancarova Milada, Lothe Ragnhild A, Fossa Sophie |
Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study. Journal of translational medicine 2007 5 (1): 70. Oldenburg Jan, Kraggerud Sigrid M, Brydøy Marianne, Cvancarova Milada, Lothe Ragnhild A, Fossa Sophie |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: